Compare NCEL & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NCEL | CURX |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | Switzerland | United States |
| Employees | 11 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 11.6M |
| IPO Year | N/A | 2025 |
| Metric | NCEL | CURX |
|---|---|---|
| Price | $2.69 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.2K | ★ 5.3M |
| Earning Date | 04-10-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.89 | $0.26 |
| 52 Week High | $4.70 | $9.18 |
| Indicator | NCEL | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 56.19 |
| Support Level | $2.44 | $0.37 |
| Resistance Level | $3.16 | $0.51 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 0.00 | 44.12 |
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.